BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2014

Feb 7, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2014-02-06

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-02-06	Common Stock	M	4000	$12.99	Acquired	54740	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-02-06	Stock Option (right to buy Common Stock)	$12.99	M	4000	Disposed	2016-05-10	Common Stock (4000)	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10000	Indirect
Common Stock	10000	Indirect
Common Stock	10000	Indirect
Common Stock	10000	Indirect
Common Stock	20000	Indirect

Footnotes

F1: The reporting person and his spouse act as trustees for the Bienaime Family Trust.

F2: The reporting person's spouse is trustee of each child's trust.

F3: Original option grant vests 6/48th on November 11, 2006, and 1/48th on the 11th day of every month thereafter

F4: Reflects the number of stock options outstanding after the transaction from this specific stock option grant.